Your browser doesn't support javascript.
loading
Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis.
Boland, Brigid S; Bagi, Preet; Valasek, Mark A; Chang, John T; Bustamante, Ranier; Madlensky, Lisa; Sandborn, William J; Harismendy, Olivier; Gupta, Samir.
Afiliação
  • Boland BS; Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Bagi P; Inflammatory Bowel Disease Center, University of California San Diego, La Jolla, California, USA.
  • Valasek MA; Inflammatory Bowel Disease Center, University of California San Diego, La Jolla, California, USA.
  • Chang JT; Department of Pathology, University of California San Diego, La Jolla, California, USA.
  • Bustamante R; Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Madlensky L; Inflammatory Bowel Disease Center, University of California San Diego, La Jolla, California, USA.
  • Sandborn WJ; Veterans Affairs San Diego Healthcare System, San Diego, California, USA.
  • Harismendy O; Veterans Affairs San Diego Healthcare System, San Diego, California, USA.
  • Gupta S; Department of Family Medicine & Public Health, University of California San Diego, La Jolla, California, USA.
Am J Gastroenterol ; 111(5): 746-8, 2016 05.
Article em En | MEDLINE | ID: mdl-27151126
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Polipose Intestinal / Infliximab Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Polipose Intestinal / Infliximab Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos